Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Human Immunodeficiency Virus (HIV) Prevention Projects for the Commonwealth of Puerto Rico and the United States Virgin Islands, Program Announcement (PA) Number PS 08-803, 13239 [08-1013]

Download as PDF Federal Register / Vol. 73, No. 49 / Wednesday, March 12, 2008 / Notices organization, financing, and delivery of health care services. The Council is composed of members of the public, appointed by the Secretary, and Federal ex-officio members. DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Meeting of the National Advisory Council for Healthcare Research and Quality Agency for Healthcare Research and Quality (AHRQ). ACTION: Notice of public meeting. AGENCY: pwalker on PROD1PC71 with NOTICES SUMMARY: In accordance with section l0(a) of the Federal Advisory Committee Act, this notice announces a meeting of the National Advisory Council for Healthcare Research and Quality. DATES: The meeting will be held on Friday, April 4, 2008, from 9 a.m. to 3 p.m. ADDRESSES: The meeting will be held at the Eisenberg Conference Center, Agency for Healthcare Research and Quality, 540 Gaither Road, Rockville, Maryland 20850. FOR FURTHER INFORMATION CONTACT: Deborah Queenan, Coordinator of the Advisory Council, at the Agency for Healthcare Research and Quality, 540 Gaither Road, Rockville, Maryland, 20850, (301) 427–1330. For press-related information, please contact Karen Migdail at (301) 427–1855. If sign language interpretation or other reasonable accommodation for a disability is needed, please contact Mr. Donald L. Inniss, Director, Office of Equal Employment Opportunity Program, Program Support Center, on (301) 443–1144, no later than March 21, 2008. The agenda, roster, and minutes are available from Ms. Bonnie Campbell, Committee Management Officer, Agency for Healthcare Research and Quality, 540 Gaither Road, Rockville, Maryland 20850. Ms. Campbell’s phone number is (301) 427–1554. SUPPLEMENTARY INFORMATION: I. Purpose The National Advisory Council for Healthcare Research and Quality was established in accordance with section 921 (now section 931) of the Public Health Service Act (42 U.S.C. 299c). In accordance with its statutory mandate, the Council is to advise the Secretary of the Department of Health and Human Services and the Director, Agency for Healthcare Research and Quality (AHRQ), on matters related to actions of the Agency to enhance the quality, improve the outcomes, reduce the costs of health care services, improve access to such services through scientific research, and to promote improvements in clinical practice and in the VerDate Aug<31>2005 19:30 Mar 11, 2008 Jkt 214001 II. Agenda On Friday, April 4, the Council meeting will convene at 9 a.m., with the call to order by the Council Chair and approval of previous Council minutes. The AHRQ director will present her update on current research, programs, and initiatives. The agenda will include an introduction of new Council members, discussion of a strategy for expanding measure development, and a discussion of program priorities for the 2010 budget. The final agenda will be available on the AHRQ Web site at http;//www.ahrq.gov no later than March 31, 2008. Dated: February 29, 2008. Carolyn M. Clancy, Director. [FR Doc. E8–4680 Filed 3–11–08; 8:45 am] 13239 requires its consideration of this matter on less than 15 days notice to the public and that no earlier notice of this meeting was possible. Contact Person for More Information: Beth Wolfe, Prevention Support Office, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, 8 Corporate Square Boulevard,M/S E07, Atlanta, GA 30329, Telephone (404) 639–8531. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: March 7, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 08–1013 Filed 3–10–08; 9:14 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4160–90–M Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Human Immunodeficiency Virus (HIV) Prevention Projects for the Commonwealth of Puerto Rico and the United States Virgin Islands, Program Announcement (PA) Number PS 08– 803 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 5 p.m.–7:30 p.m., March 24, 2008 (Closed) 9 a.m.–5 p.m., March 25, 2008 (Closed) 9 a.m.–5 p.m., March 26, 2008 (Closed) Place: W Atlanta Hotel at Perimeter Center, 111 Perimeter Center, Atlanta, GA 30346. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘Human Immunodeficiency Virus (HIV) Prevention Projects for the Commonwealth of Puerto Rico and the United States Virgin Islands, PA# PS 08–803. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) determines that agency business PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 National Center for Injury Prevention and Control/Initial Review Group, (NCIPC/IRG) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned review group: Time and Date: 8 a.m.–8:30 a.m., March 31, 2008 (Open). 8:30 a.m.–5p.m., March 31, 2008 (Closed). Place: Embassy Suites Atlanta— Buckhead, 3285 Peachtree Road, NE., Atlanta, GA 30305, Telephone (404) 261–7733. Status: Portions of the meetings will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5, U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to section 10(d) of Public Law 92–463. Purpose: This group is charged with providing advice and guidance to the Secretary, Department of Health and Human Services, and the Director, CDC, concerning the scientific and technical merit of grant and cooperative agreement applications received from academic institutions and other public and private profit and nonprofit organizations, including State and local government agencies, to conduct E:\FR\FM\12MRN1.SGM 12MRN1

Agencies

[Federal Register Volume 73, Number 49 (Wednesday, March 12, 2008)]
[Notices]
[Page 13239]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 08-1013]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Human Immunodeficiency Virus (HIV) Prevention 
Projects for the Commonwealth of Puerto Rico and the United States 
Virgin Islands, Program Announcement (PA) Number PS 08-803

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting.
    Time and Date:
    5 p.m.-7:30 p.m., March 24, 2008 (Closed)
    9 a.m.-5 p.m., March 25, 2008 (Closed)
    9 a.m.-5 p.m., March 26, 2008 (Closed)
    Place: W Atlanta Hotel at Perimeter Center, 111 Perimeter 
Center, Atlanta, GA 30346.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c) (4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of ``Human Immunodeficiency Virus (HIV) 
Prevention Projects for the Commonwealth of Puerto Rico and the 
United States Virgin Islands, PA PS 08-803.
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB 
Prevention (NCHHSTP) determines that agency business requires its 
consideration of this matter on less than 15 days notice to the 
public and that no earlier notice of this meeting was possible.
    Contact Person for More Information: Beth Wolfe, Prevention 
Support Office, National Center for HIV/AIDS, Viral Hepatitis, STD, 
and TB Prevention, CDC, 8 Corporate Square Boulevard,M/S E07, 
Atlanta, GA 30329, Telephone (404) 639-8531.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: March 7, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 08-1013 Filed 3-10-08; 9:14 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.